Merck & Co., Inc. (MRK) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	67.3B	64.9B	64.2B	60.1B	59.3B
Cost of Revenue	15.5B	18.2B	15.2B	16.1B	17.4B
Gross Profit	51.8B	46.7B	49.0B	44.0B	41.9B
Operating Expenses
R&D Expense	29.3B	12.5B	17.9B	30.5B	13.5B
SG&A Expense	11.3B	10.7B	10.1B	9.9B	9.7B
General & Admin Expense	2.9B	—	7.7B	7.6B	7.5B
Selling & Marketing Expense	—	—	2.4B	2.3B	2.2B
Other Expenses	250.0M	—	716.0M	620.0M	373.0M
Total Operating Expenses	40.9B	23.2B	28.8B	41.0B	23.6B
Cost and Expenses	56.4B	41.4B	43.9B	57.2B	41.0B
Operating Income (EBIT)	10.9B	23.5B	20.2B	3.0B	18.3B
Non-Operating
Interest Income	104.0M	343.0M	415.0M	365.0M	157.0M
Interest Expense	936.0M	1.4B	1.3B	1.1B	962.0M
Net Interest Income	(832.0M)	(1.0B)	(856.0M)	(781.0M)	(805.0M)
Other Non-Op Income/Expense	(6.2B)	(2.4B)	(285.0M)	(1.1B)	(1.8B)
Non-Operating Income (excl Interest)	3.5B	1.1B	(986.0M)	(81.0M)	876.0M
EBT (Pre-Tax Income)	4.8B	21.1B	19.9B	1.9B	16.4B
Income Tax Expense	2.3B	2.8B	2.8B	1.5B	1.9B
Bottom Line
Net Income	2.5B	18.3B	17.1B	365.0M	14.5B
Earnings from Cont. Ops	2.4B	18.3B	17.1B	377.0M	14.5B
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	2.5B	18.3B	17.1B	365.0M	14.5B
Per Share
Basic EPS	$0.98	$7.30	$6.76	$0.14	$5.73
Diluted EPS	$0.97	$7.28	$6.74	$0.14	$5.71
Revenue Per Share	$27.16	$25.95	$25.34	$23.60	$23.41
Shares
Basic Shares Outstanding	2.5B	2.5B	2.5B	2.5B	2.5B
Diluted Shares Outstanding	2.5B	2.5B	2.5B	2.5B	2.5B
Profitability Metrics
EBITDA	13.0B	28.3B	25.7B	6.9B	21.3B
D&A	5.6B	5.8B	4.5B	3.9B	3.9B
EBIT	7.5B	22.4B	21.2B	3.0B	17.4B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026